Modifies provisions relating to gender transition procedures
HB 1672 repeals and replaces Missouri’s existing section 191.1720 to create the “Missouri Save Adolescents from Experimentation (SAFE) Act.” The bill prohibits health care providers from knowingly performing gender transition surgery on anyone under 18. It also bars prescribing or administering cross-sex hormones or puberty-blocking drugs to minors for the purpose of gender transition, with a limited grandfathering provision for minors who were already receiving such treatment before August 28, 2023, through March 1, 2027.
The bill defines a number of terms used in the restriction, including biological sex, gender transition, gender transition surgery, cross-sex hormones, puberty-blocking drugs, and health care provider. It also creates a private right of action against providers who violate the law, with extended filing deadlines, a rebuttable presumption of harm in certain infertility cases, mandatory treble damages, attorney’s fees, and court costs. Violations are also treated as unprofessional conduct subject to license revocation by the appropriate licensing authority.
HB 1672 would significantly affect Missouri health care law by restricting gender-affirming medical treatment for minors and exposing providers to both professional discipline and civil liability. The bill includes exceptions for individuals with medically verifiable disorders of sex development, for treatment of complications caused by prior transition-related care, and for procedures necessary to prevent imminent death or major bodily impairment. It also states that it does not apply to speech protected by the First Amendment.
Because no committee transcript or vote history is provided, the available context does not show recorded debate or formal legislative support/opposition. Based on the bill’s subject matter and structure, the measure appears to be framed as a child-protection and medical-regulation bill by supporters, while likely drawing opposition from those concerned about access to gender-affirming care, medical discretion, and civil-rights implications. The bill’s detailed liability provisions and broad restrictions suggest the main contention would be over whether the state should prohibit these treatments for minors and penalize providers so severely.
HB 1672 would amend Missouri law by replacing section 191.1720 with a new statutory framework that bans gender transition surgery, cross-sex hormones, and puberty-blocking drugs for minors when used for gender transition. It would also create a new civil cause of action, impose treble damages and attorney’s fees, and require professional discipline, including possible license revocation, for providers who violate the law. The bill would affect health care providers, minors seeking gender-affirming care, licensing boards, and courts handling related lawsuits.
No votes or committee transcripts are included, so there is no direct record of floor or committee sentiment in the provided materials. From the bill text alone, the measure is strongly restrictive and reflects a clear policy position against gender transition medical interventions for minors, suggesting support from lawmakers favoring limits on such care and opposition from those who view the bill as an intrusion into medical decision-making and patient care. The absence of recorded debate prevents a more specific assessment of legislative sentiment.
The central point of contention is the prohibition on gender-affirming medical treatment for minors, especially the ban on puberty blockers and cross-sex hormones and the requirement that providers lose their licenses for violations. Another major issue is the private right of action, which allows lawsuits with enhanced damages, long filing windows, and limited waiver options, potentially increasing provider exposure. Supporters are likely to emphasize child protection and the bill’s exceptions for disorders of sex development and emergency care, while opponents are likely to focus on access to care, physician autonomy, and the bill’s legal and financial penalties.